SHISEIDO FutureLX Day/Jour (SHISEIDO AMERICA INC.)


Welcome to the PulseAid listing for the SHISEIDO Future drug offered from SHISEIDO AMERICA INC.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: SHISEIDO AMERICA INC.
NON-PROPRIETARY NAME: Ensulizole, Octinoxate and Octocrylene
SUBSTANCE NAME: ENSULIZOLE; OCTINOXATE; OCTOCRYLENE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: CREAM
MARKETING CATEGORY NAME: OTC MONOGRAPH NOT FINAL
START MARKETING DATE: 2009-09-01
END MARKETING DATE: 0000-00-00


SHISEIDO Future LX Day/Jour HUMAN OTC DRUG Details:

Item DescriptionSHISEIDO Future LX Day/Jour from SHISEIDO AMERICA INC.
LABELER NAME: SHISEIDO AMERICA INC.
DEA SCHEDULE:
ACTIVE STRENGTH: 1.02; 2.5; 2.55(g/51g; g/51g; g/51g)
START MARKETING DATE: 2009-09-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 52686-221_cfb1b58a-f158-4159-8659-c6cd46bf9560
PRODUCT NDC: 52686-221
APPLICATION NUMBER: part352

Other ENSULIZOLE; OCTINOXATE; OCTOCRYLENE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
SHISEIDO AMERICA INC.SHISEIDO Future